ArticleTranslational oncology2024

Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways.

Silvia García-Roman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.